Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 29, 2011

Expedeon, Protein Discovery Ink Merger Deal

  • Expedeon and Protein Discovery have decided to come together to create a supplier of products for protein research. The new Expedeon created under the merger agreement will have a portfolio of protein analysis and purification products.

    Protein Discovery, founded in 2001, develops and commercializes sample preparation products for protein analysis by mass spectrometry. Its flagship product is the Gelfree® 8100 Fractionation System. It partitions complex protein mixtures into user-selectable, liquid-phase molecular weight fractions. The company also has consumables like the FASP™ Protein Digestion kits and PPS Silent® Surfactant.

    Expedeon develops tools and reagents for protein discovery and analysis. Its products include solutions for protein separation, quantitation, visualization, purification, protection, and refolding. Its portfolio includes RunBlue® electrophoresis precast gels, InstantBlue® protein stain, and Nvoy™ protein stabilization products. It has offices in Cambridge, U.K., and San Diego, CA, and products are sold through a network of partners around the globe.

    The new entity will remain headquartered in Cambridge, U.K. "This transaction represents an important step toward our strategic goal of becoming a premier, global provider of innovative product solutions for protein analysis," says Heikki Lanckriet, founder and CEO of Expedeon, who will be CEO of the new company.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »